In a study of 53 female patients, including women with benign ovarian tumors and those with ovarian cancer, plasma concentrations of acyl ghrelin were significantly higher compared to the control population, whereas there was no difference between cancer and control groups when total ghrelin plasma levels were compared (48). This evidence concerns the gene GHRL and ovarian carcinoma.